Total Payments
$4,586
2024 Payments
$302.40
Companies
35
Transactions
229
Medicare Patients
600
Medicare Billing
$34,886
Payment Breakdown by Category
Food & Beverage$4,586 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,586 | 229 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Lilly USA, LLC | $575.44 | 22 | $0 (2024) |
| Novo Nordisk Inc | $477.70 | 31 | $0 (2023) |
| Bayer Healthcare Pharmaceuticals Inc. | $338.65 | 13 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $319.04 | 16 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $268.30 | 10 | $0 (2022) |
| Abbott Laboratories | $222.57 | 11 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $206.55 | 13 | $0 (2022) |
| PFIZER INC. | $198.25 | 11 | $0 (2021) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $187.87 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $171.58 | 4 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $302.40 | 6 | Bayer Healthcare Pharmaceuticals Inc. ($123.93) |
| 2023 | $322.77 | 12 | Gilead Sciences, Inc. ($123.27) |
| 2022 | $1,098 | 60 | Boehringer Ingelheim Pharmaceuticals, Inc. ($168.94) |
| 2021 | $886.17 | 51 | Takeda Pharmaceuticals U.S.A., Inc. ($185.52) |
| 2020 | $296.19 | 19 | Novo Nordisk Inc ($47.60) |
| 2019 | $837.12 | 46 | Lilly USA, LLC ($282.39) |
| 2018 | $843.95 | 35 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($171.72) |
All Payment Transactions
229 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $123.93 | General |
| Category: Cardio-renal | ||||||
| 09/26/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | Cash or cash equivalent | $103.90 | General |
| Category: Diabetes | ||||||
| 07/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Diabetes Care | ||||||
| 06/26/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.60 | General |
| Category: Oncology | ||||||
| 02/13/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: Diabetes Care | ||||||
| 01/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.77 | General |
| Category: Diabetes Care | ||||||
| 12/19/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Diabetes Care | ||||||
| 10/26/2023 | Gilead Sciences, Inc. | Vemlidy (Drug) | Food and Beverage | In-kind items and services | $123.27 | General |
| Category: HBV | ||||||
| 10/17/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Gastroenterology | ||||||
| 09/07/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Diabetes Care | ||||||
| 08/08/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Diabetes Care | ||||||
| 03/19/2023 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Diabetes Care | ||||||
| 03/02/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.53 | General |
| Category: Cardio-renal | ||||||
| 02/23/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: NEUROSCIENCE | ||||||
| 02/15/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Diabetes | ||||||
| 02/08/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: NEUROSCIENCE | ||||||
| 01/18/2023 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: Cardio-renal | ||||||
| 01/13/2023 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Oncology | ||||||
| 12/08/2022 | Abbott Laboratories | FREESTYLE LIBRE (Device) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Diabetes Care | ||||||
| 12/08/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Cardio-renal | ||||||
| 11/09/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Cardio-renal | ||||||
| 10/31/2022 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), BEXSERO | Food and Beverage | In-kind items and services | $15.93 | General |
| Category: VACCINES | ||||||
| 10/25/2022 | Bayer HealthCare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Cardio-renal | ||||||
| 09/30/2022 | Abbott Laboratories | FREESTYLE LIBRE 2 (Device) | Food and Beverage | In-kind items and services | $24.43 | General |
| Category: Diabetes Care | ||||||
| 09/22/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.01 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 28 | 30 | $5,636 | $1,712 |
| 2022 | 5 | 144 | 167 | $25,606 | $10,952 |
| 2021 | 9 | 209 | 241 | $28,242 | $12,671 |
| 2020 | 6 | 219 | 233 | $29,374 | $9,551 |
Total Patients
600
Total Services
671
Medicare Billing
$34,886
Procedure Codes
22
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 14 | $3,144 | $1,106 | 35.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 16 | $2,492 | $606.33 | 24.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 64 | 78 | $16,068 | $6,089 | 37.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 32 | 40 | $5,600 | $2,328 | 41.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 17 | 17 | $3,145 | $2,114 | 67.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 13 | 13 | $546.00 | $355.72 | 65.2% |
| 81002 | Urinalysis, manual test | Office | 2022 | 18 | 19 | $247.00 | $65.38 | 26.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 51 | 66 | $13,596 | $5,327 | 39.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 40 | 56 | $7,840 | $3,366 | 42.9% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 17 | 17 | $1,802 | $1,109 | 61.6% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 24 | 24 | $1,440 | $889.92 | 61.8% |
| 0004A | Fee covid-19 vac 1 res | Office | 2021 | 19 | 19 | $1,140 | $704.52 | 61.8% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 12 | 12 | $600.00 | $444.96 | 74.2% |
| 0002A | Adm sarscov2 30mcg/0.3ml 2nd | Office | 2021 | 11 | 11 | $660.00 | $407.88 | 61.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 24 | 24 | $1,008 | $379.68 | 37.7% |
| 81002 | Urinalysis, manual test | Office | 2021 | 11 | 12 | $156.00 | $41.76 | 26.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 55 | 60 | $12,360 | $2,674 | 21.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 51 | 59 | $8,260 | $2,331 | 28.2% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 38 | 38 | $3,989 | $2,311 | 57.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 11 | 11 | $2,035 | $1,208 | 59.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 53 | 54 | $2,268 | $853.54 | 37.6% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 11 | 11 | $462.00 | $173.17 | 37.5% |
About Dr. Kristin Grimes, DO
Dr. Kristin Grimes, DO is a Internal Medicine healthcare provider based in Baker, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/18/2013. The National Provider Identifier (NPI) number assigned to this provider is 1558603563.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kristin Grimes, DO has received a total of $4,586 in payments from pharmaceutical and medical device companies, with $302.40 received in 2024. These payments were reported across 229 transactions from 35 companies. The most common payment nature is "Food and Beverage" ($4,586).
As a Medicare-enrolled provider, Grimes has provided services to 600 Medicare beneficiaries, totaling 671 services with total Medicare billing of $34,886. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Baker, LA
- Active Since 03/18/2013
- Last Updated 02/11/2021
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1558603563
Products in Payments
- JARDIANCE (Drug) $363.35
- Kerendia (Drug) $338.65
- Ozempic (Drug) $317.87
- TRULICITY (Drug) $279.43
- XARELTO (Drug) $206.55
- VYVANSE (Drug) $184.22
- FARXIGA (Drug) $171.58
- TRINTELLIX (Drug) $151.67
- Vascepa (Drug) $148.05
- FREESTYLE LIBRE 3 (Device) $142.05
- MOUNJARO (Drug) $129.70
- Vemlidy (Drug) $123.27
- Livalo (Drug) $117.72
- EVENITY (Biological) $116.22
- TOUJEO (Drug) $114.85
- XIFAXAN (Drug) $99.55
- NUEDEXTA (Drug) $98.56
- INGREZZA (Drug) $93.56
- CYCLOSET (Drug) $88.32
- CHANTIX (Drug) $81.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.